Search Results - Roberto Iacovelli

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert by Amelia Altavilla, Roberto Iacovelli, Giuseppe Procopio, Enrico Cortesi

    Published in Therapeutic Advances in Urology (2012-06-01)
    Get full text
    Article


  2. 2

    Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma by Daniele Alesini, Claudia Mosillo, Giuseppe Naso, Enrico Cortesi, Roberto Iacovelli

    Published in Therapeutic Advances in Urology (2015-10-01)
    Get full text
    Article


  3. 3

    [Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost o... by Daniela Paola Roggeri, Alessandro Roggeri, Anna Maria Provenzano, Francesca Ludovica Boffo, Roberto Iacovelli

    Get full text
    Article


  4. 4

    Prevalence of Prostate Cancer at Different Clinical Stages in Italy: Estimated Burden of Disease Based on a Modelling Study by Federico Spandonaro, Daniela D’Angela, Barbara Polistena, Paolo Bruzzi, Roberto Iacovelli, Irene Luccarini, Paola Stagni, Alessia Brigido

    Published in Biology (2021-03-01)
    Get full text
    Article


  5. 5

    Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies. by Roberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, Claudia Maggi, Antonella Palazzo, Francesca Ricchini, Filippo de Braud, Maria Di Bartolomeo

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  6. 6

    Gemcitabine-Induced Extensive Skin Necrosis by Sara D'epiro, Monica Salvi, Carlo Mattozzi, Simona Giancristoforo, Marco Campoli, Ramona Zanniello, Cecilia Luci, Laura Macaluso, Sara Giovannoni, Roberto Iacovelli, Stefano Calvieri, Antonio Giovanni Richetta

    Published in Case Reports in Medicine (2012-01-01)
    Get full text
    Article


  7. 7

    Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status. by Filippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, Maria Grazia Facciorusso, Federica Perrone, Adele Testi, Roberto Iacovelli, Rosalba Miceli, Ilaria Bossi, Giorgia Leone, Massimo Milione, Giuseppe Pelosi, Filippo de Braud

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  8. 8

    Management of Small Renal Masses: Literature and Guidelines Review by Antonio Silvestri, Filippo Gavi, Maria Chiara Sighinolfi, Simone Assumma, Enrico Panio, Daniele Fettucciari, Giuseppe Pallotta, Or Schubert, Cristina Carerj, Mauro Ragonese, Pierluigi Russo, Riccardo Bientinesi, Nazario Foschi, Chiara Ciccarese, Roberto Iacovelli, Bernardo Rocco

    Published in International Brazilian Journal of Urology (2025-08-01)
    Get full text
    Article


  9. 9

    Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy? by Pierluigi Russo, Filippo Marino, Francesco Rossi, Francesco Pio Bizzarri, Mauro Ragonese, Francesco Dibitetto, Giovanni Battista Filomena, Denise Pires Marafon, Chiara Ciccarese, Roberto Iacovelli, Savio Domenico Pandolfo, Achille Aveta, Simone Cilio, Luigi Napolitano, Nazario Foschi

    Published in Medicina (2023-11-01)
    Get full text
    Article


  10. 10

    Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study by Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine

    Published in Journal for ImmunoTherapy of Cancer (2022-01-01)
    Get full text
    Article


Search Tools: